[1]
Bonek , R. 2022. Ozanimod in the therapy of relapsing-remitting multiple sclerosis – case series. Medycyna Faktow (J EBM). 15, 2(55) (Jun. 2022), 236-239. DOI:https://doi.org/10.24292/01.MF.0222.18.